Kolexia
Decousus Hervé Médecine interne
Decousus Hervé
Médecine interne
CHU Saint-Étienne
Saint-Étienne, France
76 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Thrombose veineuse Thrombose Thromboembolisme veineux Embolie pulmonaire Thromboembolie Hémorragie Embolie Maladie aigüe Complications cardiovasculaires de la grossesse

Collaborateurs

Voir plus
Mismetti Patrick
Mismetti Patrick
Hôpital Nord CHU Saint-Étienne - Loire, Saint-Priest-en-Jarez, France
Bertoletti Laurent
Bertoletti Laurent
Hôpital Nord CHU Saint-Étienne - Loire, Saint-Priest-en-Jarez, France
Leizorovicz Alain
Leizorovicz Alain
Hôpital Laennec, Saint-Herblain, France
Meyer Guy
Meyer Guy
Hôpital Européen Georges Pompidou, Paris, France

Industries

Voir plus
Bayer
1 collaboration(s)
Dernière en 2017
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
ETNA-VTE: Non-Interventional Study on Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe
Essai Clinique (Daiichi Sankyo)   18 février 2022
Using numerical modeling and simulation to assess the ethical burden in clinical trials and how it relates to the proportion of responders in a trial sample.
PloS one   11 octobre 2021
Ruling out deep vein thrombosis in patients with superficial vein thrombosis: external validation of the ICARO score.
Journal of thrombosis and thrombolysis   19 février 2019
Risk of recurrent venous thromboembolism according to baseline risk factor profiles.
Blood advances   19 février 2019
Cancer Venous Thromboembolism (VTE): A Phase 3b, Prospective, Randomized, Open-label, Blind Evaluator (PROBE) Study Evaluating the Efficacy and Safety of (LMW) Heparin/Edoxaban Versus Dalteparin in Venous Thromboembolism Associated With Cancer
Essai Clinique (Daiichi Sankyo)   08 février 2019
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).: A Phase 3, Randomized, Parallel-Group, Multi-Center, Multi-National Study for the Evaluation of Efficacy and Safety of (LMW) Heparin/Edoxaban Versus (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis (DVT) and or Pulmonary Embolism (PE).
Essai Clinique (Daiichi Sankyo)   08 février 2019
Evaluation of direct oral anticoagulants in superficial-vein thrombosis.
The Lancet. Haematology   19 octobre 2018
Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP).
Blood   06 juillet 2018
Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study.
Thrombosis journal   31 mai 2018
Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study.
Thrombosis journal   01 mai 2018